Author:
Huang Szu-Yu,Fu Hung-Chun,Wu Chen-Hsuan,Wang Shao-Chi,Ou Yu-Che,Tsai Ching-Chou,Chen Ying-Yi,Huang Szu-Wei,Wang Ying-Wen,Lin Hao
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference25 articles.
1. ASTEC Study Group, Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373(9658):125–136
2. Baser E, Gungor T, Togrul C, Turkoglu O, Celen S (2014) Preoperative prediction of poor prognostic parameters and adjuvant treatment in women with pure endometrioid type endometrial cancer: what is the significance of tumor markers? Eur J Gynaecol Oncol 35(5):513–518
3. Boronow RC (1997) Surgical staging of endometrial cancer: evolution, evaluation, and responsible challenge–a personal perspective. Gynecol Oncol 66(2):179–189
4. Bruns F, Micke O, Halek G, Schäfer U, Willich N (2003) Carcinoembryonic antigen (CEA)–a useful marker for the detection of recurrent disease in endometrial carcinoma patients. Anticancer Res 23(2A):1103–1106
5. Chung HH, Kim JW, Park NH, Song YS, Kang SB, Lee HP (2006) Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer. Acta Obstet Gynecol Scand 85(12):1501–1505
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献